Bexil (BXLC) Research & Development: $0.00 Mil (TTM As of Dec. 2011)


BXLC Bexil Corp BXLC
12 GF Score
Price $42.50
View Full Analysis

What is Bexil Research & Development?

Bexil BXLC 12 Research & Development is $0.00 Mil as of Dec. 2011. GuruFocus rates BXLC with a GF Score™ of 12/100.

Research & Development is the aggregate amount of research and development expenses during the year. Bexil's Research & Development for the six months ended in Dec. 2011 was $0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2011 was $0.00 Mil.

Bexil  (OTCPK:BXLC) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Bexil Research & Development Related Terms

Bexil Research & Development Historical Data

* Premium members only.

The historical data trend for Bexil's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bexil Research & Development Chart

Bexil Annual Data
Trend Dec04 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11
Research & Development
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Bexil Semi-Annual Data
Dec04 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11
Research & Development Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00
BXLC
12GF Score
Bexil Corp BXLC
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bexil Research & Development Calculation

This is the expense the company spent on research and development.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Research & Development for the trailing twelve months (TTM) ended in Dec. 2011 was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $0.00 Mil mean?
Bexil (BXLC) has a Research & Development of $0.00 Mil as of Dec. 2011. Research and development expense is the total cost for research and development activities. View historical data on Bexil and its competitors.
Is Bexil's Research & Development too high?
Bexil's current Research & Development is $0.00 Mil. Overall, Bexil has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Bexil's Research & Development compare to NOM and TETAA?
Bexil's Research & Development of $0.00 Mil can be compared against companies in the Asset Management industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for an Asset Management company?
A good Research & Development depends on the Asset Management industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Bexil and its competitors. Bexil's current Research & Development is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bexil stock overvalued right now?
Bexil (BXLC) has a current Research & Development of $0.00 Mil. The current Research & Development is $0.00 Mil. Bexil's overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Bexil (BXLC), the current Research & Development is $0.00 Mil as of Dec. 2011. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Bexil Business Description

Address P.O. Box 4, Walpole, NH, USA, 03608
Bexil Corp is engaged in investment management with an objective to increase book value per share over time for the benefit of its stockholders. The company is engaged through a wholly owned subsidiary in investment management.
12GF Score

Get the complete analysis for BXLC

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$42.50
Price